Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership24,449 shares
Latest Disclosed Value $ 1,420,731
ProShare Advisors LLC reports 8.52% decrease in ownership of PCVX / Vaxcyte, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 24,449 shares of Vaxcyte, Inc. (US:PCVX) valued at $1,420,731 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 26,725 shares of Vaxcyte, Inc.. This represents a change in shares of -8.52% during the quarter. The current value of the position is $1,191,155 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F VAXCYTE COM 92243G108 24,449 -2,276 -8.52 1,421 15.17 0.0021
2026-02-06 2025-12-31 13F VAXCYTE COM 92243G108 26,725 2,524 10.43 1,233 41.56 0.0022
2025-11-06 2025-09-30 13F VAXCYTE COM 92243G108 24,201 -6,408 -20.94 872 -12.46 0.0018
2025-08-07 2025-06-30 13F VAXCYTE COM 92243G108 30,609 -2,083 -6.37 995 -19.37 0.0020
2025-05-08 2025-03-31 13F VAXCYTE COM 92243G108 32,692 -8,183 -20.02 1,234 -63.12 0.0028
2025-02-14 2024-12-31 13F VAXCYTE COM 92243G108 40,875 11,729 40.24 3,346 0.48 0.0076
2024-11-14 2024-09-30 13F VAXCYTE COM 92243G108 29,146 8,212 39.23 3,331 110.76 0.0082
2024-08-13 2024-06-30 13F VAXCYTE COM 92243G108 20,934 -5,733 -21.50 1,581 -13.23 0.0042
2024-05-08 2024-03-31 13F VAXCYTE COM 92243G108 26,667 5,060 23.42 1,822 34.29 0.0048
2024-02-14 2023-12-31 13F VAXCYTE COM 92243G108 21,607 3,285 17.93 1,357 45.18 0.0041
2023-11-13 2023-09-30 13F VAXCYTE COM 92243G108 18,322 302 1.68 934 3.89 0.0029
2023-08-10 2023-06-30 13F VAXCYTE COM 92243G108 18,020 4,030 28.81 900 71.56 0.0026
2023-05-26 2023-03-31 13F/A-1 VAXCYTE COM 92243G108 13,990 -1,770 -11.23 524 -30.60 0.0016
2023-05-12 2023-03-31 13F VAXCYTE COM 92243G108 13,990 -1,770 524 0.0017
2023-02-02 2022-12-31 13F VAXCYTE COM 92243G108 15,760 4,833 44.23 756 188.17 0.0027
2022-11-07 2022-09-30 13F VAXCYTE COM 92243G108 10,927 464 4.43 262 14.91 0.0010
2022-08-01 2022-06-30 13F VAXCYTE COM 92243G108 10,463 -3,364 -24.33 228 -31.74 0.0008
2022-05-10 2022-03-31 13F VAXCYTE COM 92243G108 13,827 -2,428 -14.94 334 -13.70 0.0007
2022-02-08 2021-12-31 13F VAXCYTE COM 92243G108 16,255 -72 -0.44 387 -6.52 0.0008
2021-11-12 2021-09-30 13F VAXCYTE COM 92243G108 16,327 -3,217 -16.46 414 -5.91 0.0012
2021-08-13 2021-06-30 13F VAXCYTE COM 92243G108 19,544 4,750 32.11 440 50.68 0.0013
2021-05-14 2021-03-31 13F VAXCYTE COM 92243G108 14,794 2,897 24.35 292 -7.59 0.0009
2021-02-09 2020-12-31 13F VAXCYTE COM 92243G108 11,897 11,897 316 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.